Associate Professor Matt Dun from the HMRI Precision Medicine Research Program won for his work in taming free radicals to increase response to standard-of-care treatments for children with high-risk leukaemias that become treatment resistant.

With high-risk children’s leukaemia, cancer cells can ‘escape’ from treatment and hide in the bone marrow or spleen, only to return and re-establish an active disease.

Associate Professor Dun’s work aims to target the machinery that allows those cells to resist treatment.


Associate Professor Matt Dun

Project type 
Project Grant
Year of funding